Gentiva Health Services Upgraded by Robert W. Baird to “Neutral” (GTIV)
Gentiva Health Services (NASDAQ:GTIV) was upgraded by investment analysts at Robert W. Baird from an “underperform” rating to a “neutral” rating in a note issued to investors on Thursday, AnalystRatings.NET reports. The firm currently has a $14.00 target price on the stock, up from their previous target price of $7.00. Robert W. Baird’s price objective indicates a potential upside of 63.93% from the stock’s previous close.
Shares of Gentiva Health Services (NASDAQ:GTIV) traded up 62.24% during mid-day trading on Thursday, hitting $13.855. 3,230,682 shares of the company’s stock traded hands. Gentiva Health Services has a 52 week low of $7.35 and a 52 week high of $13.85. The stock has a 50-day moving average of $8.27 and a 200-day moving average of $10.52. The company’s market cap is $509.4 million.
Gentiva Health Services (NASDAQ:GTIV) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.13 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.11 by $0.02. The company had revenue of $487.50 million for the quarter, compared to the consensus estimate of $491.51 million. During the same quarter last year, the company posted $0.23 earnings per share. Gentiva Health Services’s revenue was up 17.3% compared to the same quarter last year. On average, analysts predict that Gentiva Health Services will post $0.90 earnings per share for the current fiscal year.
GTIV has been the subject of a number of other recent research reports. Analysts at Raymond James upgraded shares of Gentiva Health Services from an “underperform” rating to a “market perform” rating in a research note on Thursday. Separately, analysts at Piper Jaffray cut their price target on shares of Gentiva Health Services from $12.00 to $11.00 in a research note on Friday, May 9th. Finally, analysts at CRT Capital initiated coverage on shares of Gentiva Health Services in a research note on Tuesday, April 8th. They set a “buy” rating and a $10.50 price target on the stock. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $11.96.
Gentiva Health Services, Inc (NASDAQ:GTIV) is engaged in providing home health services and hospice services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.